Revenue Breakdown
Composition ()
No data
Revenue Streams
Masimo Corp (MASI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Healthcare, accounting for 99.9% of total sales, equivalent to $371.20M. Another important revenue stream is other. Understanding this composition is critical for investors evaluating how MASI navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Masimo Corp maintains a gross margin of 59.95%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 20.34%, while the net margin is 15.01%. These profitability ratios, combined with a Return on Equity (ROE) of 23.43%, provide a clear picture of how effectively MASI converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, MASI competes directly with industry leaders such as GMED and PEN. With a market capitalization of $9.16B, it holds a significant position in the sector. When comparing efficiency, MASI's gross margin of 59.95% stands against GMED's 64.85% and PEN's 68.02%. Such benchmarking helps identify whether Masimo Corp is trading at a premium or discount relative to its financial performance.
